Global Blood Therapeutics, Inc. Accumulated Other Comprehensive Income
Global Blood Therapeutics, Inc. had Accumulated Other Comprehensive Income of -$3.97 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2022-08-08
- 2022-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.97M.
- 2022-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.96M.
- 2021-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $100.00K.
- 2021-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $221.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2022-06-30 | -$3.97M 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$1.96M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $100.00K 10-Q · filed 2022-08-08 |
| 2021-09-30 | $221.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $302.00K 10-Q · filed 2021-08-03 |
| 2021-03-31 | $121.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $302.00K 10-K · filed 2022-02-23 |
| 2020-09-30 | $720.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.23M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $1.22M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $754.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $978.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.19M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $576.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | -$48.00K 10-K · filed 2020-02-26 |
| 2018-09-30 | -$381.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$242.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | -$325.00K 10-Q · filed 2018-05-07 |
| 2017-12-31 | -$336.00K 10-K · filed 2019-02-27 |
| 2017-09-30 | -$197.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$268.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$179.00K 10-Q · filed 2017-05-01 |
| 2016-12-31 | -$166.00K 10-K · filed 2018-02-27 |